Abstract:Background: Brain-derived neurotrophic factor (BDNF) plays an important role in neuronal plasticity, and its dysregulation has been associated with the pathogenesis of mood and anxiety disorders. Prolactin (PRL) is a pituitary hormone which is also produced as a cytokine by immune cells and could be a neurotrophic factor regulating the functional activity of stress-related mechanisms.Aim: To investigate the possible relationship between depressive state and BDNF and PRL genotypes or levels with special reference to severity of depression.Methods: Participants of 18–70 years with a clinical diagnosis of depressive disorder of at least moderate severity were included. These patients had not been treated with antidepressant drugs before admission to hospital during the preceding period of the last 6 months, and 54.5% had never been treated with antidepressant drugs during their entire life. The DNA was genotyped for rs1341239 within the prolactin and for rs6265, rs7124442, and rs11030104 within the BDNF gene. Rs11030104 violated the Hardy-Weinberg equilibrium distribution and was excluded from further analyses. BDNF and prolactin concentration was measured in serum by MAGPIX multiplex analyzer (Luminex, USA) using MILLIPLEX® MAP kit (Merck, Germany). Genetic associations were determined by sequentially regressing prolactin, BDNF, 17-items Hamilton's Depression (HAMD-17) and Clinical Global Impression scale, Severity (CGI-S) ratings, and depression (absent/present) on the available SNPs. Genetic associations were evaluated assuming an additive model.Results: A total of 186 depressed patients (of which 169 were women) and 94 healthy controls (67 women) were genotyped. After excluding subjects without genetic information on all three study SNPs, 217 remained of whom 138 suffered from depression. Within depressed patients we observed an association of rs6265 with HAMD-17: mean difference (MD) 2.33 (95%CI 0.49; 4.16; p = 0.014) and CGI-S: MD 0.38 (95%CI 0.09; 0.66; p = 0.011). No significant association was observed between the prolactin SNP rs1341239 and prolactin levels. Similarly the mean differences of BDNF SNPs did not show an association with BDNF: rs6265 −0.042 ln(pg/ml) (95%CI −0.198; 0.113), and rs7124442 0.006 ln(pg/ml) (95%CI −0.117; 0.130). No other association reached statistical significance.Conclusion: We observed a significant association between BDNF gene variant rs6265 and the severity of depression in newly admitted, antidepressant treatment-free, depressed patients. Actual PRL and BDNF levels were not elevated sufficiently in depressed patients to reach statistical significance and were not associated with the studied genotypes.

The Relationship between Level of BDNF in Serum and Depressive Symptoms and Cognitive Dysfunction of Patients with Major Depression

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Association of Anhedonia with Brain-Derived Neurotrophic Factor and Interleukin-10 in Major Depressive Disorder

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

Low BDNF Levels in Serum Are Associated with Cognitive Impairments in Medication-Naïve Patients with Current Depressive Episode in BD II and MDD.

An Analysis of Serum Levels of BDNF and Relative Factors in Depressive Patients

Relationship between serum BDNF level and Parkinson disease depression

Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder

The Level of Serum Brain-Derived Neurotrophic Factor is Associated with the Therapeutic Efficacy of Modified Electroconvulsive Therapy in Chinese Patients with Depression

Association Between Depressive Symptoms and Serum Brain-Derived Neurotrophic Factor Levels in Patients With First-Episode and Drug-Naïve Schizophrenia

Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction

Altered BDNF levels are associated with cognitive impairment in Parkinson's disease patients with depression

Serum Levels of Brain-Derived Neurotrophic Factor Are Associated with Depressive Symptoms in Patients with Systemic Lupus Erythematosus

Association Between the Enriched Environment Level and Serum Brain-Derived Neurotrophic Factor (BDNF) in Patients with Major Depressive Disorder

The Plasma Brain-Derived Neurotrophic Factor Levels and Cognitive Functions in Late Onset Depressive Patients

Brain-derived Neurotrophic Factor Expression in Peripheral Leukocytes of Patients with Subsyndromal Symptomatic Depression

Association of BDNF gene polymorphism with major depression and cognitive functions

Plasma Brain-Derived Neurotrophic Factor (BDNF) Concentration and the BDNF Val66Met Polymorphism in Suicide: a Prospective Study in Patients with Depressive Disorder

Relationship between the effect of modified electroconvulsive therapy and brain-derived neurotrophic factor(BDNF) gene polymorphism in patients with major depressive disorder

Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients

Role of Brain-Derived Neurotrophic Factor in Aged Patients with Type 2 Diabetes Complicated with Depression